The 52 references in paper Mikhail Dolgushin Borisovich, Pavel Tulin Evgenyevich, Akgul Odzharova Ataevna, Nadezhda Mescheryakova Andreevna, Denis Nevzorov Igorevich, Mikhail Menkov Aleksandrovich, Yuriy Patyutko Ivanovich, Boris Dolgushin Ivanovich, Михаил Долгушин Борисович, Павел Тулин Евгеньевич, Акгуль Оджарова Атаевна, Надежда Мещерякова Андреевна, Денис Невзоров Игоревич, Михаил Меньков Александрович, Юрий Патютко Иванович, Борис Долгушин Иванович (2015) “КТ-перфузия в дифференциальной диагностике опухолей печени // CT-Perfusion in Differential Diagnostics of Hepatic Tumors” / spz:neicon:medvis:y:2015:i:5:p:18-31

1
Bray F. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet. Oncology. 2012; 13 (8): 790–801.
(check this in PDF content)
2
GLOBOCAN: estimated cancer incidence, mortality, and prevalence worldwide in 2012. IARC. 2014 [http:// globocan.iarc.fr/Pages/fact_sheets_cancer.aspx] (дата обращения 01.03.2015 г.)
(check this in PDF content)
3
Патютко Ю.И., Сагайдак И.В., Чучуев Е.С. Гепатоцеллюлярный рак печени. Бюллетень медицинских интернет-конференций. 2011; 1: 35–61.
(check this in PDF content)
4
Mirk P., Rubaltelli L., Bazzocchi M. et al. Ultrasonographic patterns in hepatic hemangiomas. J. Clin. Ultrasound. 1982; 10: 373–378.
(check this in PDF content)
5
Matsui O. et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991; 178 (2): 493–497.
(check this in PDF content)
6
Delbeke D., Martin W.H. Evaluation of benign vs malignant hepatic lesions with PET. Arch. Surg.1998; 133: 510–516.
(check this in PDF content)
7
Терновой С.К., Шахиджанова С.В. Магнитнорезонансная томография в диагностике очаговых заболеваний печени (обзор литературы). Медицинская визуализация. 1999; 4: 14–23.
(check this in PDF content)
8
Tiferes D.A., D’Ippolito G. Liver neoplasms: imaging characterization. Radiology. 2008; 41 (2): 119–127.
(check this in PDF content)
9
Bartolotta T.V. Focal liver lesions: contrast-enhanced ultrasound. Abdom. Imaging. 2009; 34: 193–209.
(check this in PDF content)
10
Talbot J. N. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J. Nucl. Med. 2010; 51 (11): 1699–1706.
(check this in PDF content)
11
Esschert J. W. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. Eur. J. Nucl. Med. Molec. Imaging. 2011; 38 (3): 436–440.
(check this in PDF content)
12
Медведева Б.М., Лукьянченко А.Б. Возможности МРТ в диагностике гепатоцеллюлярного рака у пациентов с циррозом печени. REJR. 2013; 3 (2): 63–70.
(check this in PDF content)
13
Тулин П.Е., Долгушин М.Б., Патютко Ю.И. и др. ПЭТ/КТ с 18F-ФДГ и 18F-холином в диагностике смешанного гепатохолангиоцеллюлярного рака. Клиническое наблюдение. Диагностическая и интервенционная радиология. 2015; 9 (1): 14–19.
(check this in PDF content)
14
Кармазановский Г.Г., Шимановский Н.Л. Диаг ностическая эффективность нового магнитно-резонансного контрастного средства “Примовист” (гадоксетовая кислота) при выявлении первичных и вторичных опухолей печени. Медицинская визуализация. 2007; 6: 135–143.
(check this in PDF content)
15
Pantoja E. Angiography in liver hemangioma. Am. J. Roentgenol. 1968; 104 (4): 874–879.
(check this in PDF content)
16
Zajko A.B. Angiography of liver transplantation patients. Radiology. 1985; 157 (2): 305–311.
(check this in PDF content)
17
Долгушин М.Б., Пронин И.Н., Фадеева Л.М. и др. ИПSWAN (3.0 тесла МРТ) и КТ-перфузия в комплексной оценке структурных особенностей метастазов в головной мозг и злокачественных глиом. Лучевая диагностика и терапия. 2012; 3: 41–51.
(check this in PDF content)
18
Kety S., Schmidt C. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J. Clin. Invest. 1948; 27: 476–483.
(check this in PDF content)
19
Meier P., Zierler K. On the theory of the indicator-dilution measurement of blood flow and volume. J. Appl. Physiol. 1954; 6: 731–744.
(check this in PDF content)
20
Axel L. Cerebral blood flow determination by rapidsequence computed tomography. Radiology. 1980; 137: 679–686.
(check this in PDF content)
21
Пронин И.Н., Фадеева Л.М., Захарова Н.Е. и др. Перфузионная КТ: исследование мозговой гемодинамики в норме. Медицинская визуализация. 2007; 3: 8–12.
(check this in PDF content)
22
Mathieu D. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology. 1986; 160 (1): 53–58.
(check this in PDF content)
23
Miles K.A. Measurement of tissue perfusion by dynamic computed tomography. Br. J. Radiol. 1991; 64 (761): 409–412.
(check this in PDF content)
24
Lev M., Nichols S. Computed tomographic angiography and computed tomographic perfusion imaging of hyperacute stroke. Magn. Reson. Imaging. 2000; 11: 283–287.
(check this in PDF content)
25
Корниенко В.Н., Пронин И.Н. Диагностическая нейрорадиология. М.: Андреева Т.М., 2006. 1327 c.
(check this in PDF content)
26
Hwang S. Microcirculation of the liver. Venous embolization of the liver. London: Springer, 2011: 9–13.
(check this in PDF content)
27
Борзяк Э.И., Бочаров В.Я., Сапин М.Р. Анатомия человека. М.: Медицина, 1987; 2: 33–38.
(check this in PDF content)
28
Сапин М.Р., Швецов Э.В. Анатомия человека. Ростовна-Дону: Феникс, 2004. 557 с.
(check this in PDF content)
29
Ternberg J.L., Butcher H.R. Blood-flow relation between hepatic artery and portal vein. Science. 1965; 150 (3699): 1030–1031.
(check this in PDF content)
30
Araki T. Dynamic CT densitometry of hepatic tumors. Am. J. Roentgenol. 1980; 135 (5): 1037–1043.
(check this in PDF content)
31
Foley W.D. Contrast enhancement technique for dynamic hepatic computed tomographic scanning. Radiology. 1983; 147 (3): 797–803.
(check this in PDF content)
32
Freeny P.C., Marks W.M. Hepatic perfusion abnormalities during CT angiography: detection and interpretation. Radiology. 1986; 159 (3): 685–691.
(check this in PDF content)
33
Shamsi K. Focal nodular hyperplasia of the liver: radiologic findings. Abdom. Imaging. 1993; 18 (1): 32–38.
(check this in PDF content)
34
Miles K.A., Hayball M.P., Dixon A.K. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993; 188 (2): 405–411.
(check this in PDF content)
35
Blomley M.J.K., Coulden R., Bufkin C. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest. Radiol. 1993; 28: 72–77.
(check this in PDF content)
36
Blomley M.J.K. Liver perfusion studied with ultrafast CT. J. Comput. Assisted Tomogr. 1995; 19 (3): 424–433.
(check this in PDF content)
37
Groell R. Quantitative perfusion parameters of focal nodular hyperplasia and normal liver parenchyma as determined by electron beam tomography. Br. J. Radiol. 1995; 68 (815): 1185–1189.
(check this in PDF content)
38
Tong R.T. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 2004; 64 (11): 3731– 3736.
(check this in PDF content)
39
Medina J. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004; 39 (5): 1185–1195.
(check this in PDF content)
40
Дударев В.С., Анкифеев В.В. Современная интервенционная радиология. Новости лучевой диагностики. 1997; 1: 26–27.
(check this in PDF content)
41
Долгушин Б.И. Интервенционная радиология в онкологии. Лучевая диагностика и интервенционная радиология в клинической онкологии. 2002; 1: 50–51.
(check this in PDF content)
42
Виршке Э.Р. Чрескатетерная артериальная химиоэмболизация неоперабельного гепатоцеллюлярного рака. Медицинская визуализация. 2007; 5: 68–75.
(check this in PDF content)
43
Таразов П.Г. Рентгеноэндоваскулярные вмешательства в лечении первичного рака печени. Практическая онкология. 2008; 9 (4): 209–215.
(check this in PDF content)
44
Гранов Д.А., Таразов П.Г. Рентгеноэндоваскулярные вмешательства в лечении злокачественных опухолей печени. СПб.: Фолиант, 2002. 288 с.
(check this in PDF content)
45
Galanski M. Spiral and multislice computed tomography of the body. Stuttgart: Thieme, 2003: 18–26.
(check this in PDF content)
46
Xu H.X. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J. Clin. Ultrasound. 2006; 34(6): 261–272.
(check this in PDF content)
47
Гранов А. М., Таразов П. Г., Гранов Д. А. Интервенци онная радиология в комбинированном хирургическом лечении рака печени. Вопросы онкологии. 2002; 42 (2): 480–481.
(check this in PDF content)
48
Hanafusa K. Differential diagnosis of early homogeneously enhancing hepatocellular carcinoma and hemangioma by two-phase CT. J. Comput. Assist. Tomogr. 1997; 21(3): 361–368.
(check this in PDF content)
49
Гранов А.М., Полысалов В.Н. Гемангиомы печени. СПб.: Гиппократ,1999: 21–24.
(check this in PDF content)
50
Carlson S.K. CT of focal nodular hyperplasia of the liver. Am. J. Roentgenol. 2000; 174 (3): 705–712.
(check this in PDF content)
51
Hussain S.M. Focal nodular hyperplasia: findings at stateof-the-art MR imaging, US, CT, and pathologic analysis. Radiographics. 2004; 24 (1): 3–17.
(check this in PDF content)
52
Adson M.A. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology.1983; 84: 994–1002.
(check this in PDF content)